ProgenaMatrix
Commercial- Indications
- Diabetic foot ulcers, Venous stasis ulcers, Pressure ulcers, Partial-thickness burns, Surgical wounds, Donor sites
Company intelligence / Profile preview
ProgenaCare
Marietta, Georgia, USAprogenacare.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ProgenaCare has two main commercial products for advanced wound care. ProgenaMatrix is the first and only commercially available human keratin matrix for wound healing. revyve Antimicrobial Wound Gel uses a patented antibiofilm technology combined with PHMB in a thermo-reversible hydrogel to provide superior antimicrobial activity and promote moist wound healing environments. Both products are used clinically and have demonstrated efficacy in supporting natural healing processes and reducing infection risk in chronic and acute wounds[1][2][3][4].
- Therapeutic areas
- OtherDermatologyEndocrinology
- Modalities
- DeviceBiologic (specifically human keratin matrix)Hydrogel-based drug delivery therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Kane Biotech Inc.
Beyond the preview
Go deeper on ProgenaCare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProgenaCare.